SSH - SAVANNAH INC. — History
CCN 112011 | 3-year financial timeline | COVID resilience: 48/100
🛡️ Public data only — no PHI permitted on this instance.
$22M
Latest Revenue (FY2022)
+5.7%
Revenue CAGR (3yr)
3.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $19M | $22M | $22M | +0.0% | +5.7% |
| Operating Expenses | $18M | $19M | $21M | +11.9% | +8.8% |
| Operating Margin | 8.8% | 13.7% | 3.5% | -74.8% | -37.5% |
| Net Income | $2M | $3M | $1M | -74.8% | -33.9% |
| Licensed Beds | 40 | 40 | 40 | +0.0% | +0.0% |
| Total Patient Days | 10,148 | 10,493 | 11,666 | +11.2% | +7.2% |
| Medicare Day % | 40% | 37% | 46% | +25.1% | +7.4% |
| Medicaid Day % | 4% | 6% | 5% | -28.2% | +1.3% |
COVID Impact & Recovery
Resilience Score: 48/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +11.7% ($19M → $22M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+5.7%
This Hospital
+7.6%
State Avg
Latest Margin
3.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $23M | 0.8% |
| FY2024 (proj) | $24M | -1.9% |
| FY2025 (proj) | $25M | -4.6% |